Elanco Animal Health Incorporated (ELAN) vs Kiniksa Pharmaceuticals International, plc (KNSA)
- Elanco Animal Health Incorporated ELAN 23.55 +0.04%
- Kiniksa Pharmaceuticals International, plc KNSA 78.59 −1.69%
Elanco Animal Health Incorporated and Kiniksa Pharmaceuticals International, plc are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.8B against $6.2B — 1.9× the size. Elanco Animal Health Incorporated has negative trailing earnings, so its P/E is not meaningful; Kiniksa Pharmaceuticals International, plc trades at 73.4×. Kiniksa Pharmaceuticals International, plc grew revenue faster over the last twelve months: 58.9% against 12.0%. Kiniksa Pharmaceuticals International, plc has the higher net margin (9.59% vs −3.96%) and the higher return on invested capital (48.9% vs 0.51%). Across the 19 metrics below, Kiniksa Pharmaceuticals International, plc leads on 13 and Elanco Animal Health Incorporated on 6.
Valuation
Profitability
| Metric | ELAN | KNSA | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 55.36% | 89.82% | 53.94% |
| Operating margin | 1.61% | 11.92% | 0.00% |
| Net margin | (3.96%) | 9.59% | 0.00% |
| Free cash flow margin | 7.55% | 21.74% | 0.00% |
| Return on equity | (2.98%) | 14.04% | (0.40%) |
| Return on assets | (1.46%) | 10.36% | (3.32%) |
| Return on invested capital | 0.51% | 48.87% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack